Nina Dusílková

Oncogenic MicroRNAs: miR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early breast cancer in serum

Marek Sochor, Petra Bašová, Michal Pešta et al. · BMC Cancer · 2014 · 170 citations · Full text

Medicine, Cancer Biology, Oncology +17

Plasma miR-155, miR-203, and miR-205 are Biomarkers for Monitoring of Primary Cutaneous T-Cell Lymphomas

Nina Dusílková, Petra Bašová, Jindřich Polívka et al. · International Journal of Molecular Sciences · 2017 · 36 citations · Full text

Medicine, Oncology, Pathology +17

Oncogenic microRNA-155 and its target PU.1: an integrative gene expression study in six of the most prevalent lymphomas

Hana Hušková, Katarina Korecka, Josef Karban et al. · International Journal of Hematology · 2015 · 22 citations

Medicine, Cancer Biology, Oncology +15

Analysis of 5-Azacytidine Resistance Models Reveals a Set of Targetable Pathways

Ľubomír Minařík, Kristýna Pimková, Juraj Kokavec et al. · Cells · 2022 · 11 citations · Full text

Medicine, Oncology, Pharmacology +17

Somatic mutation dynamics in MDS patients treated with azacitidine indicate clonal selection in patients-responders

Kamila Polgárová, Karina Vargová, Vojtěch Kulvait et al. · Oncotarget · 2017 · 10 citations · Full text

Medicine, Molecular Genetics, Molecular Medicine +17